Provided by Tiger Trade Technology Pte. Ltd.

Alzamend Neuro, Inc

1.56
-0.0700-4.29%
Post-market: 1.580.0200+1.28%19:50 EDT
Volume:244.11K
Turnover:376.02K
Market Cap:7.47M
PE:-0.59
High:1.60
Open:1.57
Low:1.49
Close:1.63
52wk High:2.68
52wk Low:0.8400
Shares:4.79M
Float Shares:4.78M
Volume Ratio:1.48
T/O Rate:5.11%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.6287
EPS(LYR):-11.3245
ROE:-373.18%
ROA:-163.99%
PB:10.19
PE(LYR):-0.14

Loading ...

Alzamend Neuro - Files to Register Resale of up to 98.4 Mln Common Shares by Selling Stockholder - SEC Filing

THOMSON REUTERS
·
Yesterday

Alzamend Neuro registers to sell 98.39M shares of common stock for holders

TIPRANKS
·
Yesterday

Alzamend Neuro Phase 1/2A AL001 Lithium fMRI Data Wins Poster Slot at SfN Neuroscience 2026

Reuters
·
Aug 20

Alzamend Neuro Price Target Raised to $26.00/Share from $25.00 by Ascendiant Capital

Dow Jones
·
Aug 19

Alzamend Neuro Phase 1/2A AL001 Lithium Imaging Data Wins Oral Slot at ISMRM X-Nuclei MR Workshop

Reuters
·
Aug 18

Alzamend Neuro Initial Beneficial Ownership Filing Names Hyperscale Data as Director by Deputization

Reuters
·
Aug 05

Alzamend Neuro Announces Initial Closing of Securities Purchase Agreement with Ault Lending

THOMSON REUTERS
·
Aug 04

Alzamend Neuro Secures $25 Million Preferred Stock Financing

TIPRANKS
·
Aug 04

Alzamend Neuro Sells 7,500 Series D Preferred Shares for $7.5 Million in Private Placement

Reuters
·
Aug 04

Alzamend Neuro’s AL001 Lithium Study Reaches Completion, Setting Up Next Clinical Steps

TIPRANKS
·
Jul 30

Alzamend Neuro Inc Reports Results for the Quarter Ended April 30 - Earnings Summary

Reuters
·
Jul 28

Alzamend Neuro Inc Expected to Post a Loss of 67 Cents a Share - Earnings Preview

Reuters
·
Jul 25

Alzamend Neuro FY26 Net Loss Widens 94% to $8.77 Million

Reuters
·
Jul 23

Alzamend Neuro Director Lynne Fahey Mcgrath Dies

Reuters
·
Jul 22

Alzamend Neuro Inc Expected to Post a Loss of 67 Cents a Share - Earnings Preview

Reuters
·
Jul 18

Alzamend Neuro Shareholders Approve Governance and Capital Measures

TIPRANKS
·
Apr 18

Alzamend Neuro shareholders approved reverse stock split proposal at annual meeting

Reuters
·
Apr 18

Top Insider Makes Bold New Move on Alzamend Neuro Stock

TIPRANKS
·
Apr 17

Alzamend Neuro director Milton C. Ault III acquires 108,388 shares for $108,897

Reuters
·
Apr 17

Analysts Offer Insights on Healthcare Companies: Neurogene (NGNE), Alzamend Neuro (ALZN) and Cardiol Therapeutics (CRDL)

TIPRANKS
·
Apr 08